The new facility, which at 3,800sqm is three times the size of Icon’s previous central laboratory, houses capacity for microbiology, molecular diagnostics, flow-cytrometry, endocrinology and radio immunoassays (RIA).
The contract research organisation's (CRO) laboratory also features four times as much sample handling capacity, which will provide a number of operational advantages according to CEO Peter Gray.
He suggested that: “The extra capacity in our Dublin laboratory enables Icon to extend our capabilities to support clients’ demands for more sophisticated testing.
“Icon Central Laboratories Dublin will continue to act as an important central hub for global trials and we look forward to delivering effective laboratory services to an even greater number of sponsors and investigators around the world.”